论文部分内容阅读
目的评价经尿道等离子汽化电切术治疗良性前列腺增生(BPH)的安全性和疗效。方法自2007年3月至2011年5月采用经尿道等离子汽化电切术(TUPKVP)治疗良性前列增生155例,患者年龄55~88岁,平均74岁。前列腺大小25~144g,术后随访1~12个月。结果 TUPKVP平均手术时间50min(20~140min),无1例电切综合征发生。术后国际前列腺症状评分(IPSS)由术前的25.4分下降至6.4分左右;生活质量评分由术前的5.2分下降至2.2分左右。各项指标手术前后比较差异有统计学意义(P均<0.05)。结论 TUPKP治疗良性前列腺增生创伤小、并发症少、安全可靠、疗效确切。
Objective To evaluate the safety and efficacy of transurethral vaporization of the prostate in the treatment of benign prostatic hyperplasia (BPH). Methods From March 2007 to May 2011, 155 cases of benign prostatic hyperplasia were treated by transurethral plasma-assisted vaporization (TUPKVP). The patients were 55 to 88 years old with an average of 74 years. Prostate size 25 ~ 144g, followed up for 1 to 12 months. Results The average operation time of TUPKVP was 50min (20 ~ 140min), none of the resection syndrome occurred. Postoperative International Prostate Symptom Score (IPSS) decreased from preoperative 25.4 points to about 6.4 points; quality of life score decreased from 5.2 points before surgery to 2.2 points. The indexes before and after surgery were significantly different (P <0.05). Conclusion TUPKP treatment of benign prostatic hyperplasia trauma, fewer complications, safe and reliable, the exact effect.